Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    logo
    19 February 2025

    Epitopea announces license and research collaboration agreement with MSD to identify cryptigenTM tumor-specific antigens

    Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, announces a license and research collaboration agreement with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) to identify CryptigenTM tumor-specif...

    Sphere Bio’s APAC distributor network
    9 April 2025

    Sphere Bio expands APAC distribution network to strengthen presence in region

    Operational scale-up accelerates global growth strategy to increase regional access and technical supportCambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, announces a significant ...

    Gary Jennings, Innovation Director, The EpiCentre
    9 April 2025

    The 8Cs of smart business expansion: A simple framework for going big, the right way

    By Gary Jennings, Innovation Director, The EpiCentre.

    The Role of AI and Omnichannel Strategies in Healthcare Marketing
    10 April 2025

    The role of AI and omnichannel strategies in healthcare marketing

    Co-authored by Jose Maria (Chema) Guido Avila, SanofiThe pharmaceutical industry is at a pivotal moment. As the world grows more digital and patients become more informed, traditional marketing strategies are losing their effectiveness. Doctors are overwhelmed with information, and pati...

    Dr Del Trezise, Chair of ELRIG
    8 April 2025

    ELRIG appoints Dr Del Trezise as Chair

    Cambridge, UK, 8 April 2025: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the drug discovery community, has appointed Dr Del Trezise as Chair of the Board. In this role, he will lead ELRIG’s mission to foster collaboration, innovation, and knowledge-sh...

    Mukta Acharya, Head of Tecan’s Life Sciences Business
    8 April 2025

    IBL International collaborates with Grifols on advanced biomarker panels

    Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platformMännedorf, Switzerland, April 8, 2025 – IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostic...

    Connectivity for Schools
    7 April 2025

    Schools broadband & Breathe Technology: A powerful partnership for education IT

    Breathe Technology is proud to be the authorised support partner for Schools Broadband in Peterborough, together we can give you a smarter, safer, and more streamlined solution.Together, we offer: ...

    www.tecan.com
    3 April 2025

    Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits

    Männedorf, Switzerland, April 3, 2025 – Tecan Group (SIX Swiss Exchange: TECN), announces an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The ...

    OBN logo
    3 April 2025

    BioTrinity 2025: Over 800 professionals convene to paint a picture of hope for UK life sciences

    BioTrinity 2025 welcomed over 800 delegates, matching the highest-ever attendance set in 2024.Three action-packed tracks covered investment trends, regulatory shifts, and cutting-edge scientific advancements.Nearly 10,000 meetings requested, with 2,000 in-person, fuelling partnerships a...

    Andrw Wilkes CEO of S&W
    2 April 2025

    S&W launches as a leader in the accountancy mid-market

    The independent accountancy and advisory business ( formally separate from Evelyn Partners from 31 March 2025) has launched under a new brand – S&W – building on the firm’s heritage but with a clear signal to a new, well invested, client-focused organisation at the forefront of prov...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 105
    • Page 106
    • Current page 107
    • Page 108
    • Page 109
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS